Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-19

Clinical Trial Update: Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating escalating doses of oxaliplatin with HIPEC in children and adolescents with extensive colorectal cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED